Literature DB >> 8192451

Cytofluorometric analysis of chondrotoxicity of fluoroquinolone antimicrobial agents.

G Hayem1, P X Petit, M Levacher, C Gaudin, M F Kahn, J J Pocidalo.   

Abstract

To better understand quinolone-related arthropathy, we conceived an experimental ex vivo model using cell cultures of articular chondrocytes issued from pretreated New Zealand White rabbits (NZW). Juvenile (4- to 5-week-old) NZW were orally dosed with ofloxacin or pefloxacin (300 mg/kg of body weight for 1 day) or with pefloxacin (300 mg/kg for 7 days). Adult (5-month-old) NZW were treated with pefloxacin (300 mg/kg for 1 day). Chondrocytes were enzymatically recovered from cartilage and were analyzed by cytofluorometry using 2',7'-dichlorofluorescein diacetate (DCFH-DA) and dihydrorhodamine 123 (DHR), reflecting cellular respiratory-burst activity, and rhodamine 123 (Rh123) and 10-N-nonyl-acridine orange (NAO), specific for the mitochondrial activity and mass, respectively. A significant increase in the respiratory burst was detected by DCFH-DA and DHR in all treated groups of young animals, compared with untreated control groups. No significant increase of respiratory burst was noted in older treated rabbits. The 7-day treatment resulted in a decrease in mitochondrial uptake of Rh123 and an increase in NAO uptake. Fluoroquinolone arthrotoxicity seems to involve in its early phase the respiratory burst of immature articular chondrocytes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8192451      PMCID: PMC284434          DOI: 10.1128/AAC.38.2.243

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  41 in total

1.  Mitochondria contain a distinct DNA topoisomerase.

Authors:  F R Fairfield; W R Bauer; M V Simpson
Journal:  J Biol Chem       Date:  1979-10-10       Impact factor: 5.157

2.  Improved high-performance liquid chromatographic determination of pefloxacin and its metabolite norfloxacin in human plasma and tissue.

Authors:  G Montay; J P Tassel
Journal:  J Chromatogr       Date:  1985-04-12

3.  Behavior of articular chondrocytes in cell culture.

Authors:  W T Green
Journal:  Clin Orthop Relat Res       Date:  1971 Mar-Apr       Impact factor: 4.176

4.  The effect of bacterial DNA gyrase inhibitors on DNA synthesis in mammalian mitochondria.

Authors:  F J Castora; F F Vissering; M V Simpson
Journal:  Biochim Biophys Acta       Date:  1983-09-09

5.  Probing mitochondria in living cells with rhodamine 123.

Authors:  L B Chen; I C Summerhayes; L V Johnson; M L Walsh; S D Bernal; T J Lampidis
Journal:  Cold Spring Harb Symp Quant Biol       Date:  1982

6.  Search for a DNA gyrase in mammalian mitochondria.

Authors:  F J Castora; M V Simpson
Journal:  J Biol Chem       Date:  1979-11-25       Impact factor: 5.157

7.  Chondrotoxicity of quinolones in vivo and in vitro.

Authors:  H Hildebrand; G Kempka; G Schlüter; M Schmidt
Journal:  Arch Toxicol       Date:  1993       Impact factor: 5.153

8.  Critical risk/benefit analysis of pefloxacine use in children under 15 years--the problem of arthralgias.

Authors:  M Chevais; P Reinert; M C Rondeau; R Tobelem; E Albengres; P Riant; J P Tillement
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1987-06

9.  Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation.

Authors:  D A Bass; J W Parce; L R Dechatelet; P Szejda; M C Seeds; M Thomas
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

10.  Monitoring of relative mitochondrial membrane potential in living cells by fluorescence microscopy.

Authors:  L V Johnson; M L Walsh; B J Bockus; L B Chen
Journal:  J Cell Biol       Date:  1981-03       Impact factor: 10.539

View more
  11 in total

1.  Ultrastructure of Achilles tendons of rats treated with ofloxacin and fed a normal or magnesium-deficient diet.

Authors:  M Shakibaei; K Pfister; R Schwabe; J Vormann; R Stahlmann
Journal:  Antimicrob Agents Chemother       Date:  2000-02       Impact factor: 5.191

2.  A reappraisal of quinolone tolerability. The experience of their musculoskeletal adverse effects.

Authors:  G Hayem; C Carbon
Journal:  Drug Saf       Date:  1995-12       Impact factor: 5.606

3.  Use of antimicrobials and risk of type 1 diabetes in a population-based mother-child cohort.

Authors:  A Kilkkinen; S M Virtanen; T Klaukka; M G Kenward; M Salkinoja-Salonen; M Gissler; M Kaila; A Reunanen
Journal:  Diabetologia       Date:  2005-12-13       Impact factor: 10.122

4.  Effects of ciprofloxacin and ofloxacin on adult human cartilage in vitro.

Authors:  M Menschik; J Neumüller; C W Steiner; L Erlacher; M Köller; R Ullrich; W Graninger; W B Graninger
Journal:  Antimicrob Agents Chemother       Date:  1997-11       Impact factor: 5.191

5.  Proteoglycan and collagen biochemical variations during fluoroquinolone-induced chondrotoxicity in mice.

Authors:  M A Simonin; P Gegout-Pottie; A Minn; P Gillet; P Netter; B Terlain
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

Review 6.  Adverse effects of antimicrobials via predictable or idiosyncratic inhibition of host mitochondrial components.

Authors:  Alison E Barnhill; Matt T Brewer; Steve A Carlson
Journal:  Antimicrob Agents Chemother       Date:  2012-05-21       Impact factor: 5.191

Review 7.  Toxicity of quinolones.

Authors:  R Stahlmann; H Lode
Journal:  Drugs       Date:  1999       Impact factor: 9.546

8.  Chondrotoxicity and toxicokinetics of sparfloxacin in juvenile rats.

Authors:  R Stahlmann; U Zippel; C Förster; R Schwabe; M Shakibaei; H J Merker; K Borner
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

9.  Effect of levofloxacin on glycosaminoglycan and DNA synthesis of cultured rabbit chondrocytes at concentrations inducing cartilage lesions in vivo.

Authors:  M Kato; S Takada; S Ogawara; S Takayama
Journal:  Antimicrob Agents Chemother       Date:  1995-09       Impact factor: 5.191

Review 10.  Fluoroquinolone toxicities. An update.

Authors:  P S Lietman
Journal:  Drugs       Date:  1995       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.